Blake Moore Stock Trades
U.S. Representative · R · UT-UT01
Disclosures through Jan 24
Every stock trade Blake Moore has disclosed under the STOCK Act, parsed by Coldpine. Informational only, sourced from public congressional filings. Not investment advice.
Coldpine’s read
Moore's purchase of a broad-market growth ETF in a tax-deferred IRA suggests portfolio allocation rather than a directional bet tied to his Ways and Means or Budget committee work. The 5-day disclosure lag is well inside the STOCK Act window, making the filing timely but not unusually fast. No other members traded VUG in the same window, so there is no cluster pattern to corroborate.
Bought $VUG · Jan 19
Coldpine scores and writes a rationale for every congressional trade. See the full scored analysis with Pro →
Follow Blake Moore
Get an email the moment Blake Moore discloses a new trade. Free, no card, no spam.
Most-traded tickers
Recent disclosed trades
| Date | Ticker | Asset | Type | Amount |
|---|---|---|---|---|
| Jan 19 | DISDISWalt Disney Company | Walt Disney Company (DIS) | sell | $1K–$15K |
| Jan 19 | DISDISWalt Disney Company | Walt Disney Company (DIS) | sell | $1K–$15K |
| Jan 19 | VUGVUGVanguard Growth ETF | Vanguard Growth ETF (VUG) | buy | $100K–$250K |
| Jan 19 | VUGVUGVanguard Growth ETF | Vanguard Growth ETF (VUG) | buy | $1K–$15K |
| Jan 19 | VUGVUGVanguard Growth ETF | Vanguard Growth ETF (VUG) | buy | $1K–$15K |
| Jan 19 | SPYSPYSPDR S&P 500 | SPDR S&P 500 (SPY) | buy | $15K–$50K |
| Jan 19 | SPYSPYSPDR S&P 500 | SPDR S&P 500 (SPY) | buy | $15K–$50K |
| Jan 19 | SPYSPYSPDR S&P 500 | SPDR S&P 500 (SPY) | buy | $100K–$250K |
| Jan 19 | RTXRTXRTX Corporation | RTX Corporation (RTX) | sell | $1K–$15K |
| Jan 19 | RTXRTXRTX Corporation | RTX Corporation (RTX) | sell | $1K–$15K |
| Jan 19 | MSFTMSFTMicrosoft Corporation | Microsoft Corporation (MSFT) | sell | $15K–$50K |
| Jan 19 | MSFTMSFTMicrosoft Corporation | Microsoft Corporation (MSFT) | sell | $1K–$15K |
| Jan 19 | MSFTMSFTMicrosoft Corporation | Microsoft Corporation (MSFT) | sell | $1K–$15K |
| Jan 19 | METAMETAMeta Platforms, Inc. - Class A | Meta Platforms, Inc. - Class A (META) | sell | $1K–$15K |
| Jan 19 | METAMETAMeta Platforms, Inc. - Class A | Meta Platforms, Inc. - Class A (META) | sell | $1K–$15K |
| Jan 19 | METAMETAMeta Platforms, Inc. - Class A | Meta Platforms, Inc. - Class A (META) | sell | $15K–$50K |
| Jan 19 | JNJJNJJohnson & Johnson | Johnson & Johnson (JNJ) | sell | $1K–$15K |
| Jan 19 | JNJJNJJohnson & Johnson | Johnson & Johnson (JNJ) | sell | $1K–$15K |
| Jan 19 | HQYHQYHealthEquity, Inc. | HealthEquity, Inc. (HQY) | sell | $1K–$15K |
| Jan 19 | HQYHQYHealthEquity, Inc. | HealthEquity, Inc. (HQY) | sell | $1K–$15K |
Showing 20 of 40 disclosed trades.
Sign up free for the full history, signal scores, and price-vs-trades chart. Pro adds Coldpine's read — the AI narrative on each trade.
Create a free accountData sourced from public STOCK Act disclosures. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. See full history and signal scores with Pro →